The patient is a 55-year-old male who has a medical history significant for hypertension, hyperlipidemia, and type 2 diabetes.
He has been on antihypertensive medication for the past 10 years and his blood pressure is well-controlled. His lipid profile shows elevated LDL cholesterol levels, and he has been on statin therapy for the past 5 years.
The patient was diagnosed with type 2 diabetes 8 years ago and has been managing it with oral hypoglycemic medications. His most recent hemoglobin A1c level was 7.2%, indicating fair glycemic control.
He has a past surgical history of a cholecystectomy 10 years ago, during which no complications were encountered.
His current medications include lisinopril for blood pressure control, atorvastatin for cholesterol management, and metformin for diabetes management.
During the preoperative workup, the patient's laboratory investigations were unremarkable, with a normal complete blood count and normal electrolyte levels.
The patient has been advised to stop taking any non-steroidal anti-inflammatory drugs (NSAIDs) and blood-thinning medications one week prior to surgery.
He is a non-smoker, does not consume alcohol, and denies any substance abuse. He reports a sedentary lifestyle and a body mass index (BMI) of 30, indicating obesity.
The patient does not have any known drug allergies and states that he has had no previous adverse reactions to medications.
He has been educated about the perioperative complications of surgery, including risks of infection, bleeding, and adverse reactions to anesthesia.
Postoperatively, the patient's recovery has been uncomplicated. He has been closely monitored for vital signs, wound healing, and pain control.
He was kept on prophylactic antibiotics to prevent surgical site infections and was encouraged to mobilize early to prevent deep vein thrombosis.
The patient tolerated the surgery well, resumed oral intake on the same day, and was able to ambulate without assistance by the second postoperative day.
During hospitalization, his blood glucose levels were closely monitored and managed with sliding-scale insulin therapy.
He did not experience any postoperative complications, such as wound infection, respiratory compromise, or cardiovascular events.